Company attributes
Location
Pitchbook URL
Number of Employees (Ranges)
11 – 50
Email Address
contact@purespringtx.com
Investors
Founded Date
2020
Total Funding Amount (USD)
155,000,000
Latest Funding Round Date
October 9, 2024
Latest Funding Type
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
105,000,000
University of Bristol spinout Purespring is a medtech startup that develops renal-related gene therapies. It aims to transform the lives of the 8m people in the UK who suffer from kidney diseases.
Launched in November 2020, Purespring’s approach is based on the pioneering work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the university. The research focuses on the podocyte, a cell type vital to kidney functioning.
All of Purespring’s £45.0m in total funding so far has come from Syncona, a life science investment company with a proven track-record in building innovative gene therapy companies
Timeline
No Timeline data yet.
